|
US7964571B2
(en)
|
2004-12-09 |
2011-06-21 |
Egen, Inc. |
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
|
|
HUE056941T2
(hu)
|
2004-12-22 |
2022-04-28 |
Nitto Denko Corp |
Gyógyszerhordozó és gyógyszerhordozó kit fibrózis gátlására
|
|
US20120269886A1
(en)
|
2004-12-22 |
2012-10-25 |
Nitto Denko Corporation |
Therapeutic agent for pulmonary fibrosis
|
|
DE102005039154A1
(de)
*
|
2005-08-17 |
2007-03-01 |
GÖPFERICH, Achim, Prof. Dr. |
Bioabbaubare Polymere für den Transport von Nukleinsäuren in Zellen
|
|
US9572886B2
(en)
|
2005-12-22 |
2017-02-21 |
Nitto Denko Corporation |
Agent for treating myelofibrosis
|
|
KR100825519B1
(ko)
*
|
2007-01-05 |
2008-04-25 |
주식회사 바이오폴리메드 |
키토산 기재 고분자 접합체 및 그 제조방법
|
|
US7943141B2
(en)
*
|
2007-02-28 |
2011-05-17 |
Serina Therapeutics, Inc. |
Activated polyoxazolines and compositions comprising the same
|
|
TWI407971B
(zh)
|
2007-03-30 |
2013-09-11 |
Nitto Denko Corp |
Cancer cells and tumor-related fibroblasts
|
|
WO2009009441A2
(en)
|
2007-07-06 |
2009-01-15 |
Cedars-Sinai Medical Center |
Self-assembling complex for targeting chemical agents to cells
|
|
US9144546B2
(en)
|
2007-08-06 |
2015-09-29 |
Clsn Laboratories, Inc. |
Nucleic acid-lipopolymer compositions
|
|
JP2010539245A
(ja)
|
2007-09-14 |
2010-12-16 |
日東電工株式会社 |
薬物担体
|
|
US20090130752A1
(en)
*
|
2007-11-07 |
2009-05-21 |
University Of Utah Research Foundation |
Biodegradable poly(disulfide amine)s for gene delivery
|
|
US20100285111A1
(en)
*
|
2007-11-09 |
2010-11-11 |
Northeastern University |
Self-assembling micelle-like nanoparticles for systemic gene delivery
|
|
US20090171455A1
(en)
*
|
2007-12-31 |
2009-07-02 |
Boston Scientific Scimed, Inc. |
Biodegradable polymers
|
|
WO2009089542A2
(en)
*
|
2008-01-11 |
2009-07-16 |
Serina Therapeutics, Inc. |
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
|
|
FR2928373B1
(fr)
*
|
2008-03-05 |
2010-12-31 |
Centre Nat Rech Scient |
Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
|
|
CN102027043A
(zh)
*
|
2008-03-14 |
2011-04-20 |
艾根股份有限公司 |
生物可降解的交联支链聚(亚烷基亚胺)
|
|
WO2009126933A2
(en)
*
|
2008-04-11 |
2009-10-15 |
Alnylam Pharmaceuticals, Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
|
WO2010085665A2
(en)
|
2009-01-23 |
2010-07-29 |
Cedars-Sinai Medical Center |
Targeted delivery system
|
|
KR101132413B1
(ko)
*
|
2009-05-06 |
2012-04-03 |
서울대학교산학협력단 |
Ｓａｒｓ 백신 나노전달체
|
|
US8992991B2
(en)
|
2009-05-15 |
2015-03-31 |
The Johns Hopkins University |
Multicomponent degradable cationic polymers
|
|
CN101585921B
(zh)
*
|
2009-06-18 |
2010-12-01 |
天津大学 |
温度敏感聚乙烯亚胺-接枝-聚丙烯酸寡乙二醇酯嵌段共聚物及制备方法和应用
|
|
CN102575204B
(zh)
*
|
2009-10-23 |
2015-02-25 |
荷兰联合利华有限公司 |
染料聚合物
|
|
CN101812178B
(zh)
*
|
2010-04-20 |
2012-07-04 |
武汉大学 |
还原敏感性聚乙烯亚胺衍生物及其制备方法和应用
|
|
KR101802988B1
(ko)
*
|
2010-05-14 |
2017-12-14 |
헨켈 아이피 앤드 홀딩 게엠베하 |
중합체 함유 세정 조성물, 이의 제조 방법 및 용도
|
|
BR112012030306A2
(pt)
*
|
2010-06-25 |
2019-09-24 |
Toray Industries |
polímero solúvel em água, complexo de nanopartícula solúvel em água, método de produção de um complexo de nanopartícula solúvel em água e reagente
|
|
EP2600901B1
(en)
|
2010-08-06 |
2019-03-27 |
ModernaTX, Inc. |
A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
|
|
DE19177059T1
(de)
|
2010-10-01 |
2021-10-07 |
Modernatx, Inc. |
N1-methyl-pseudouracile enthältendes ribonucleinsäuren sowie ihre verwendungen
|
|
CN102174184B
(zh)
*
|
2011-01-14 |
2012-11-21 |
中国科学院广州生物医药与健康研究院 |
一种生物可降解的聚合物及其制备方法以及核酸药物运输载体
|
|
WO2012135805A2
(en)
|
2011-03-31 |
2012-10-04 |
modeRNA Therapeutics |
Delivery and formulation of engineered nucleic acids
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
CA2848740A1
(en)
|
2011-09-16 |
2013-03-21 |
Mingxing Wang |
Amphiphilic cationic polymers for the delivery of therapeutic agents
|
|
LT3682905T
(lt)
|
2011-10-03 |
2022-02-25 |
Modernatx, Inc. |
Modifikuoti nukleozidai, nukleotidai ir nukleorūgštys bei jų naudojimas
|
|
PL2791160T3
(pl)
|
2011-12-16 |
2022-06-20 |
Modernatx, Inc. |
Kompozycje zmodyfikowanego mrna
|
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
CN104411338A
(zh)
|
2012-04-02 |
2015-03-11 |
现代治疗公司 |
用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
|
|
DE18200782T1
(de)
|
2012-04-02 |
2021-10-21 |
Modernatx, Inc. |
Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US20130337067A1
(en)
|
2012-06-15 |
2013-12-19 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Non-viral nanoparticle-based delivery system
|
|
EP2880160B1
(en)
|
2012-08-03 |
2018-09-19 |
Cedars-Sinai Medical Center |
Isolating traffic-enhancing mutants of drug delivery protein
|
|
CN103305549B
(zh)
*
|
2013-06-19 |
2015-04-22 |
四川大学 |
具有多重氧化还原刺激响应的纳米粒子基因载体系统及其制备方法和应用
|
|
US9707303B2
(en)
|
2012-10-10 |
2017-07-18 |
Sichuan University |
Reduction stimulus-responsive gene delivery system and preparation and application thereof
|
|
KR101452819B1
(ko)
|
2012-11-01 |
2014-10-23 |
국립암센터 |
환원제 반응형 이황화물 연결자 함유 고분자-광감각제 결합체 및 이를 포함하는 형광 영상 진단 및 광역학 치료용 조성물
|
|
RS63237B1
(sr)
|
2012-11-26 |
2022-06-30 |
Modernatx Inc |
Terminalno modifikovana rnk
|
|
CA2897941A1
(en)
|
2013-01-17 |
2014-07-24 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
WO2014159813A1
(en)
|
2013-03-13 |
2014-10-02 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
WO2014152211A1
(en)
|
2013-03-14 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
SI3019619T1
(sl)
|
2013-07-11 |
2021-12-31 |
Modernatx, Inc. |
Sestave, ki zajemajo sintetične polinukleotide, ki kodirajo proteine, pozvezane s crispr, in sintetične sgrna, ter metode uporabe
|
|
EP3041938A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
CA2923029A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
EA201690675A1
(ru)
|
2013-10-03 |
2016-08-31 |
Модерна Терапьютикс, Инк. |
Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности
|
|
EP3082760A1
(en)
|
2013-12-19 |
2016-10-26 |
Novartis AG |
LEPTIN mRNA COMPOSITIONS AND FORMULATIONS
|
|
JP6608370B2
(ja)
|
2014-01-17 |
2019-11-20 |
シーダーズ―シナイ メディカル センター |
受容体標的化構築物およびその使用
|
|
WO2015154059A2
(en)
|
2014-04-04 |
2015-10-08 |
Cedars-Sinai Medical Center |
Targeting trastuzumab-resistant her2+breast cancer with a her3-targeting nanoparticle
|
|
CN104109248B
(zh)
*
|
2014-06-20 |
2017-02-01 |
南开大学 |
基于桥式双环糊精主客体诱导聚集构筑的聚集体及其应用
|
|
WO2016011226A1
(en)
|
2014-07-16 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
US20170210788A1
(en)
|
2014-07-23 |
2017-07-27 |
Modernatx, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
CN104356395B
(zh)
*
|
2014-11-12 |
2016-08-17 |
苏州大学 |
一种阳离子化丝素蛋白、制备方法及其应用
|
|
WO2016077625A1
(en)
*
|
2014-11-12 |
2016-05-19 |
Stayton Patrick S |
Stabilized polymeric carriers for therapeutic agent delivery
|
|
CN105012957B
(zh)
*
|
2015-07-03 |
2019-03-22 |
上海交通大学 |
一种交联型聚乙烯亚胺作为肿瘤蛋白抗原疫苗载体的用途
|
|
US20180256730A1
(en)
*
|
2015-09-16 |
2018-09-13 |
University Of Utah Research Foundation |
A polymeric carrier for delivery of a payload to a cell
|
|
DE102017003004A1
(de)
*
|
2017-03-23 |
2018-09-27 |
Friedrich-Schiller-Universität Jena |
Kationische Polymere mit D-Fructose-Substituenten
|
|
CA3063723A1
(en)
|
2017-05-18 |
2018-11-22 |
Modernatx, Inc. |
Polynucleotides encoding tethered interleukin-12 (il12) polypeptides and uses thereof
|
|
WO2018213789A1
(en)
|
2017-05-18 |
2018-11-22 |
Modernatx, Inc. |
Modified messenger rna comprising functional rna elements
|
|
US20200268666A1
(en)
|
2017-06-14 |
2020-08-27 |
Modernatx, Inc. |
Polynucleotides encoding coagulation factor viii
|
|
US20200208152A1
(en)
|
2017-09-08 |
2020-07-02 |
Mina Therapeutics Limited |
Stabilized sarna compositions and methods of use
|
|
JP7423521B2
(ja)
|
2017-11-22 |
2024-01-29 |
モダーナティエックス・インコーポレイテッド |
フェニルケトン尿症の治療用のフェニルアラニンヒドロキシラーゼをコードするポリヌクレオチド
|
|
US20220265856A1
(en)
|
2017-11-22 |
2022-08-25 |
Modernatx, Inc. |
Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of propionic acidemia
|
|
CA3079428A1
(en)
|
2017-11-22 |
2019-05-31 |
Modernatx, Inc. |
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
|
|
US11802146B2
(en)
|
2018-01-05 |
2023-10-31 |
Modernatx, Inc. |
Polynucleotides encoding anti-chikungunya virus antibodies
|
|
US11193000B2
(en)
|
2018-02-27 |
2021-12-07 |
Soochow University |
Reversible self-repairing epoxy resin and preparation and recovery remoulding method therefor
|
|
WO2019197845A1
(en)
|
2018-04-12 |
2019-10-17 |
Mina Therapeutics Limited |
Sirt1-sarna compositions and methods of use
|
|
WO2019204392A1
(en)
*
|
2018-04-17 |
2019-10-24 |
Purdue Research Foundation |
Modifying surface of a live cell and the uses thereof
|
|
KR101992236B1
(ko)
|
2018-05-16 |
2019-06-24 |
가톨릭대학교 산학협력단 |
디셀레노디프로피오네이트의 양 말단에 폴리(입실론-카프로락톤)이 공유결합된 환원분해성 폴리(입실론-카프로락톤) 고분자, 이를 포함하는 항암용 조성물 및 약물 전달용 조성물
|
|
MA52709A
(fr)
|
2018-05-23 |
2021-03-31 |
Modernatx Inc |
Administration d'adn
|
|
US20220184185A1
(en)
|
2018-07-25 |
2022-06-16 |
Modernatx, Inc. |
Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders
|
|
EP3833762A4
(en)
|
2018-08-09 |
2022-09-28 |
Verseau Therapeutics, Inc. |
OLIGONUCLEOTIDE COMPOSITIONS FOR TARGETING CCR2 AND CSF1R AND THEIR USES
|
|
CN110859969B
(zh)
*
|
2018-08-28 |
2022-01-11 |
上海市第十人民医院 |
聚乙烯亚胺修饰的荧光素钠造影剂及其制备方法和应用
|
|
EP3846776A1
(en)
|
2018-09-02 |
2021-07-14 |
ModernaTX, Inc. |
Polynucleotides encoding very long-chain acyl-coa dehydrogenase for the treatment of very long-chain acyl-coa dehydrogenase deficiency
|
|
EP3849594A2
(en)
|
2018-09-13 |
2021-07-21 |
Modernatx, Inc. |
Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex e1-alpha, e1-beta, and e2 subunits for the treatment of maple syrup urine disease
|
|
JP2022500436A
(ja)
|
2018-09-13 |
2022-01-04 |
モダーナティエックス・インコーポレイテッドModernaTX, Inc. |
糖原病を処置するためのグルコース−６−ホスファターゼをコードするポリヌクレオチド
|
|
JP2022500444A
(ja)
|
2018-09-14 |
2022-01-04 |
モダーナティエックス・インコーポレイテッドModernaTX, Inc. |
クリグラー−ナジャー症候群の治療のためのウリジン二リン酸グリコシルトランスフェラーゼ１ファミリー、ポリペプチドａ１をコードするポリヌクレオチド
|
|
MA53734A
(fr)
|
2018-09-27 |
2021-08-04 |
Modernatx Inc |
Polynucléotides codant pour l'arginase 1 pour le traitement d'une déficience en arginase
|
|
EP3953473A1
(en)
|
2019-04-12 |
2022-02-16 |
MiNA Therapeutics Limited |
Sirt1-sarna compositions and methods of use
|
|
JP2022532078A
(ja)
|
2019-05-08 |
2022-07-13 |
アストラゼネカ アクチボラグ |
皮膚及び創傷のための組成物並びにその使用の方法
|
|
EP4158005A1
(en)
|
2020-06-01 |
2023-04-05 |
ModernaTX, Inc. |
Phenylalanine hydroxylase variants and uses thereof
|
|
AU2021377895A1
(en)
|
2020-11-13 |
2023-06-15 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
WO2022204380A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof
|
|
JP2024512026A
(ja)
|
2021-03-24 |
2024-03-18 |
モデルナティエックス インコーポレイテッド |
オルニチントランスカルバミラーゼ欠損症の治療を目的とした脂質ナノ粒子及びオルニチントランスカルバミラーゼをコードするポリヌクレオチド
|
|
WO2022204369A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia
|
|
US20240207444A1
(en)
|
2021-03-24 |
2024-06-27 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof
|
|
US20240207374A1
(en)
|
2021-03-24 |
2024-06-27 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof
|
|
EP4314292A1
(en)
|
2021-03-26 |
2024-02-07 |
MiNA Therapeutics Limited |
Tmem173 sarna compositions and methods of use
|
|
EP4355882A2
(en)
|
2021-06-15 |
2024-04-24 |
Modernatx, Inc. |
Engineered polynucleotides for cell-type or microenvironment-specific expression
|
|
WO2022271776A1
(en)
|
2021-06-22 |
2022-12-29 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
|
EP4408871A1
(en)
|
2021-10-01 |
2024-08-07 |
ModernaTX, Inc. |
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
|
|
WO2023099884A1
(en)
|
2021-12-01 |
2023-06-08 |
Mina Therapeutics Limited |
Pax6 sarna compositions and methods of use
|
|
WO2023170435A1
(en)
|
2022-03-07 |
2023-09-14 |
Mina Therapeutics Limited |
Il10 sarna compositions and methods of use
|
|
WO2023183909A2
(en)
|
2022-03-25 |
2023-09-28 |
Modernatx, Inc. |
Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia
|
|
CN114920859B
(zh)
*
|
2022-05-11 |
2023-09-26 |
宁夏医科大学总医院 |
5-氟尿嘧啶-1-丁酰基-β-环糊精第二面衍生物及制备方法及其应用
|
|
TW202412818A
(zh)
|
2022-07-26 |
2024-04-01 |
美商現代公司 |
用於暫時控制表現之經工程化多核苷酸
|
|
WO2024103225A1
(zh)
*
|
2022-11-14 |
2024-05-23 |
林桂孜 |
一种阳离子聚酯及其制备方法和应用
|
|
WO2024134199A1
(en)
|
2022-12-22 |
2024-06-27 |
Mina Therapeutics Limited |
Chemically modified sarna compositions and methods of use
|
|
WO2024197033A1
(en)
|
2023-03-21 |
2024-09-26 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of heart failure
|